Canadian panel says Vioxx is safe enough to return to market
By a vote of 12 to 1, a panel of Canadian health advisors said Thursday that Merck’s COX-2 drug Vioxx ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.